Adena E. Rosenblatt

Adena Rosenblatt practices at The University of Chicago Medical Center in Chicago, Illinois.

Adena Rosenblatt's NPI, 1922399807, was assigned on April 26, 2011. Adena Rosenblatt holds Illinois license 036141069.

Adena Rosenblatt's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Adena Rosenblatt's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Adena Rosenblatt is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Adena Rosenblatt to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Adena Rosenblatt practices. Vendor and product names are available with a free account.

Dermatology is Adena Rosenblatt's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Adena Rosenblatt is licensed in Illinois.

CMS data shows 11 Medicare services from Adena Rosenblatt across 1 procedure code in 2022, all of them office visits, for 20 Medicare patients. Medicare paid $464 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 20 Medicare patients who saw Adena Rosenblatt in 2024. 75% of them have high blood pressure, and 55% have arthritis. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Adena Rosenblatt's median patient age at 15, with 56% women.

Adena Rosenblatt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of removal of skin lesions by Adena Rosenblatt, more than 60% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 7 general payments to Adena Rosenblatt from 5 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 87% of the total. Sanofi and Genzyme US Companies paid the most, $112. It also lists 3 research payments totaling $4,632 from 2017 to 2019.